Nancy J Kelley, JD, MPP
Chief Executive Officer
CEO, Nancy J Kelley + Associates. Founding Executive Director, New York Genome Center. Architect, Launch of OmniSeq, now part of Labcorp Oncology. Co-Founder, Builds BIO+. Co-Founder, GP-write and the Center of Excellence for Engineering Biology. JD/MPP, Harvard Law School/ Kennedy School. BA, Yale University.
Manfred Stangl, MD, PhD
Chief SCIENTIFIC Officer
Head of Renal and Pancreas Transplant Service, LMU Munich. 25+ years of surgical experience. Recipient of Heinz Maier Leibnitz-Medaille for extraordinary achievements in clinical research. MD, Ludwigs-Maximilians-University (LMU), Munich.
Eric Hacherl, PhD
Chief OPERATING Officer
Previously, VP, Head of Manufacturing, Spark Therapeutics. Site General Manager and VP Operations, Catalent Gene Therapy. 15 years at Merck, Director, Global Manufacturing Operations, Large Molecule Line. PhD, Chemical Engineering, Rutgers University. MS, Soil and Water Science, University of Florida. BS, University of Delaware.
Stephan Grupp, MD, PhD
Stephan Grupp is Section Chief of the Cellular Therapy and Transplant Section, Director of the Cancer Immunotherapy Program, and Medical Director of the Cell and Gene Therapy Laboratory. He holds the Yetta Deitch Novotny Endowed Chair in Pediatric Oncology.
Gordon Tomaselli, MD
Gordon Tomaselli is the dean at Albert Einstein College of Medicine and executive vice president and chief academic officer at Montefiore Medicine. He is an expert in the fields of sudden cardiac death and arrhythmias. He is the leader of the Hopkins group that is in discussions with Kyttaro around further research with MSC-Klotho for cardiac arrest.
Todd Kilbaugh, MD
Todd Kilbaugh is an anesthesiologist and pediatric intensivist with the Department of Anesthesiology and Critical Care Medicine, medical director of the ECMO Center, and director of the Resuscitation Science Center at Children's Hospital of Philadelphia.
Gary R. Schall, JD, MBA
Co-Chair, Emerging Company & Venture Capital Practice, WilmerHale. Author & lecturer. JD, Vanderbilt. MBA, St. John’s. BS, Lehigh University.
Ariel Soiffer, JD
Partner, WilmerHale. Lecturer, Boston University School of Law. Sr. Manager, Diamond Management & Technology Consultants. JD, Boston University. BA Biochemistry, Japanese, U. Penn.
Jennifer Manning, MPA
SVP, Strategic Partnerships, Center for Breakthrough Medicines. Executive Director, Commercial Development FujiFilm and other senior business development roles at Lonza, Pantheon, and Human Genome Sciences. 14 years at Abbvie. MPA, Health Policy and Management, NYU. BA, Biological Sciences, Clemson University.
Luke Buchanan, EPA, PhD
Partner, Hertin and Partner. European Patent Attorney. PhD, Max-Planck Institute for Molecular Cell Biology and Genetics and TU Dresden. BS Biochemistry, Genetics, Molecular Biology, Chemistry, U. of Canterbury, NZ.
Leanne Larson, MHA, MPH
Principal, ZS. SVP, Parexel. VP, Outcome Sciences, a Quintiles Company. VP, Sg2. VP, ICON Clinical Research. Senior Health Science Associate, Merck. BS Community Health, U of Illinois, Urbana-Champaign. MPH, U. of Illinois, Chicago. MHA, Governors State University.
Kate McDonough, BS
Sr. Associate, Nancy J Kelley + Associates. Enterprise Account Executive, Hive. Scientist, Translational Tissue Engineering Institute, Johns Hopkins. BS Biomedical Engineering, U. Virginia.
